In March of 2020, we knew so much less than we do now about COVID-19. One thing we did know, however, was that testing would be a critical element in fighting the pandemic...
Is a deadline an obligation or an opportunity? That’s something many pharmaceutical companies, particularly in the US, are considering right now as they look ahead to November 27, 2023...
We were over the moon to be recognized for our positive impact on both the environment and local communities at the TLMI 2021 Calvin Frost Sustainability Leadership Awards...
When you start a company, your goal is to create a popular and profitable product. You are decidedly not thinking about the fact that your product will get counterfeited and sent to the gray market when it does get popular...
It’s almost peak holiday season and consumers are once again on the lookout for that perfect gift. However, this year is unlike any other with the events of the last 18-months putting stress on supply chains around the world...
Blue Bite’s RevOps Director Jon Anderson explains how to transform products into a digital platform to engage consumers in ways current channels cannot.
The COVID-19 crisis has put unprecedented stress on healthcare product manufacturers for personal protective equipment (PPE), ventilators, vaccines, and targeted treatments. Regrettably, this has also created the perfect opportunity for criminals looking to profit from the pandemic. The frontline of defence in this battle is adding a digital layer of product protection.
Plant managers are regularly challenged to increase throughput on production lines. Improvements to existing infrastructure or processes is often the best option, but this requires knowing which changes to make. This is the aim of overall equipment effectiveness (OEE): a best-practices metric that indicates how well a manufacturing operation is utilized compared to its full potential. The OEE method measures line productivity based on three key performance indicators: 100% availability (no...
Manufacturers need to make sure that marking is correct and readable to ensure compliance with regulations, transparency for customers and to minimize product rework, scrap and recalls. We talk to David Habib, Markem-Imaje’s North America Solution Architect for Packaging Integrity for an expert’s view.
Do you wish the data across your pharma serialization lines was more accessible?
As someone who has worked in enterprise software for a long time, the “disconnected” nature of packaging line data is pretty incredible. Using Systech as an example, we may see network connectivity from enterprise systems to Level 3 Guardian, but rarely visibility to Level 2 Advisor and Level 1 Sentri.
Essentially, each line is its own island. We need to change that!
